Improving uptake of biosimilars in Spain

Posted 29/04/2016

Author Ainhoa Aranguren Oyarzábal and colleagues from the Madrid Health Service (MHS), Spain, investigated how efforts to improve the uptake of biosimilars i...

Perceptions of the effectiveness and quality of... Generics/Research | Posted 29/04/2016
Samsung Bioepis starts phase III trial for beva... Biosimilars/News | Posted 29/04/2016
Colombia recommends compulsory licence for Glivec Policies & Legislation | Posted 29/04/2016
Biosimilars group launched in UK to improve bio... Biosimilars/General | Posted 29/04/2016
India’s bulk drug exports on the increase Generics/General | Posted 29/04/2016
US rheumatologists in favour of distinct names... Biosimilars/General | Posted 22/04/2016
Payers in US getting ready for biosimilars Reports | Posted 22/04/2016
Generics perceptions in patients, pharmacists a... Generics/Research | Posted 22/04/2016
Biosimilars: the clinical perspective Biosimilars/Research | Posted 22/04/2016
New administration route for epoetin alfa biosi... Biosimilars/News | Posted 22/04/2016
Australia announces price cuts for common presc... Policies & Legislation | Posted 22/04/2016
Sun Pharma to buy 14 drug brands from Novartis... Generics/News | Posted 22/04/2016
A multidisciplinary perspective on biosimilars Biosimilars/Research | Posted 15/04/2016
Substitution of generic antiepileptic drugs Generics/Research | Posted 15/04/2016
Biosimilars: management of clinical issues Biosimilars/Research | Posted 15/04/2016
BioOutsource launches ready-to-use biosimilarit... Biosimilars/News | Posted 15/04/2016
Apotex launches generic of nasal allergy treatment Generics/News | Posted 15/04/2016
India caps prices of 530 essential drugs Policies & Legislation | Posted 15/04/2016
FDA approves infliximab biosimilar Inflectra Biosimilars/News | Posted 08/04/2016
EMA recommends approval of infliximab biosimila... Biosimilars/News | Posted 08/04/2016
Biosimilars of insulin glargine Biosimilars/General | Posted 08/04/2016
European regulatory pathways for biosimilars Biosimilars/Research | Posted 08/04/2016
Teva launches generic acamprosate in US Generics/News | Posted 08/04/2016
IPRF template for summary information for biosi... Biosimilars/General | Posted 01/04/2016
How the biosimilars market is changing Biosimilars/Research | Posted 01/04/2016
Biologicals: characteristics that make them uni... Biosimilars/Research | Posted 01/04/2016
Impact of South Korea’s new drug–pricing policy... Generics/Research | Posted 01/04/2016
Biocon receives Japanese approval for insulin g... Biosimilars/News | Posted 01/04/2016
Idaho governor signs biosimilars substitution bill Policies & Legislation | Posted 01/04/2016
Costs and prices of entecavir to treat Hepatitis B Generics/Research | Posted 25/03/2016
IGBA opposes WHO biological qualifier Biosimilars/General | Posted 25/03/2016
Impact of breast cancer generics in Europe Reports | Posted 25/03/2016
Biosimilars: a new challenge in the current pha... Biosimilars/Research | Posted 25/03/2016
Oncobiologics and Premier make biosimilars deal Pharma News | Posted 25/03/2016
FDA approves Teva’s Viagra generic Generics/News | Posted 25/03/2016
Epoetin alfa biosimilar effective in treating a... Biosimilars/Research | Posted 25/03/2016
Lupin and Gavis to divest generics to appease U... Generics/General | Posted 25/03/2016
Pharmacovigilance for mAbs Biosimilars/Research | Posted 18/03/2016
US doctors poised to prescribe biosimilars Biosimilars/General | Posted 18/03/2016
Oregon passes biosimilars substitution law Policies & Legislation | Posted 18/03/2016
Benefits and concerns related to biosimilars Biosimilars/Research | Posted 18/03/2016
Is India ready to use only generics? Generics/Research | Posted 18/03/2016


FDA includes follow-on versions in its new cyclosporine guideline Posted 29/04/2016

In February 2016, the US Food and Drug Administration (FDA) issued a new draf...


Switching between originator and follow-on iron... Non‐Biological Complex Drugs/Research | Posted 22/04/2016
Follow-on intravenous iron formulations in haem... Non‐Biological Complex Drugs/Research | Posted 01/04/2016
Glatiramoid follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/03/2016
FDA includes follow-on versions in its new lipo... Non‐Biological Complex Drugs/Guidelines | Posted 26/02/2016
EU guidelines for follow-on NBCDs Non‐Biological Complex Drugs/Guidelines | Posted 22/01/2016
GDUFA regulatory priorities for 2016 include co... Non‐Biological Complex Drugs/Polices & Legislation | Posted 11/12/2015
Liposomal follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 11/12/2015
Regulations for follow-on NBCDs Non‐Biological Complex Drugs/Reports | Posted 13/11/2015
Status and regulatory issues surrounding follow... Non‐Biological Complex Drugs/Reports | Posted 05/11/2015
Follow-on glatiramer acetate (M356) claimed as... Non‐Biological Complex Drugs/Research | Posted 05/11/2015
EMA issues reflection paper for follow-on versi... Non‐Biological Complex Drugs/Guidelines | Posted 05/11/2015
FDA approves first follow-on version of glatira... Non‐Biological Complex Drugs/News | Posted 05/11/2015

Generics News Research General


Biosimilars News Research General